Lihi Segal, CEO & Co Founder of DayTwo - Feb. 23, 2017
Lihi Segal, CEO & Co-Founder of DayTwo speaking at ILTV studio about Israeli company DayTwo that has created a novel way to boost the body's ability to treat itself. www.iltv.tv
CEO & Co-Founder, Daytwo
Search every verified Lihi Segal interview, podcast appearance, and on-the-record quote โ each transcript cross-checked by AI and human review to confirm speaker identity. In a February 2017 interview, Lihi Segal, CEO and co-founder of DayTwo, discussed the company's approach to personalized nutrition based on the gut microbiome. Segal stated that traditional nutrition research had been asking the wrong question by focusing on the best diet for humans generally, arguing that the correct question is what diet is best for each individual. She explained that people respond very differently to the same food, specifically in terms of blood sugar levels, and that this variation is linked to a person's unique gut microbiome and other clinical parameters. Segal described DayTwo's solution as a service where users provide a stool sample, which the company sequences and analyzes using a machine learning algorithm. The company then provides an app that scores foods and complex meals from A+ to C-minus based on their effect on blood sugar balance. She noted that while about 10% of the US population is diabetic, nearly 38% are pre-diabetic, and that balancing blood sugar is also relevant for weight loss and general health. At the time, the service was available for pre-order in the US at a cost of approximately $2.99.
“The real answer to that is that until now we've been asking the wrong question. Until now all the nutrition related research will talk about what is the best diet for humans โ what you really need to ask is what is the best diet for me or for you.”
“People respond very differently to the same food โ you can eat a piece of bread and I will eat exactly the same piece of bread but we will have very different responses in our body, and when we're talking responses we're talking specifically blood sugar levels.”
“The gut microbiome is a very young area of research โ about five to seven years ago researchers started to heavily study the trillions of bacteria that reside in our digestive system, and due to advances in technologies scientists are now able to sequence the DNA of the gut microbiome and start linking them to health a...”
“What they showed was that people react very differently to the same food and that it all relates to our unique makeup โ our unique gut microbiome and other clinical parameters โ so they were able to tailor diets and specific foods that you can react to better than others.”
“Our solution is: we ask about your food preferences, medical history and lifestyle, then we FedEx you a kit and ask you to take a stool sample โ the only way to get to your gut microbiome โ you mail it back, we sequence it using advanced technologies and run that profile through a machine learning algorithm.”
“We then provide an app that gives you a tailored diet โ it tells you which foods and complex meals are good for you and which are not, meaning it helps you balance your blood sugar levels and it also assists in weight loss if you balance your blood sugar levels.”
“Of course diabetics care โ there's about 10% of the US population that is diabetic โ but that's just a small part: almost 38% of adults in the US are what we call pre-diabetic and they're well on their way unless they make drastic changes.”
“It's available on a pre-order basis in the US and it's going to cost around $2.99.”
Lihi Segal, CEO & Co-Founder of DayTwo speaking at ILTV studio about Israeli company DayTwo that has created a novel way to boost the body's ability to treat itself. www.iltv.tv
Sign in to search the full transcript archive, filter by topic, and access every quote from Lihi Segal.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →